Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8
Closed -$5.94K 1668
2023
Q1
$5.94K Buy
+8
New +$896 ﹤0.01% 1626
2022
Q4
Sell
-8
Closed -$1K 1628
2022
Q3
$1K Hold
8
﹤0.01% 1605
2022
Q2
$1K Hold
8
﹤0.01% 1602
2022
Q1
$1K Buy
+8
New +$875 ﹤0.01% 1542
2015
Q4
Sell
-2,000
Closed -$2K 1770
2015
Q3
$2K Buy
+2,000
New +$44.6K ﹤0.01% 1774
2015
Q2
Sell
-1,200
Closed -$4K 2119
2015
Q1
$4K Hold
1,200
﹤0.01% 2022
2014
Q4
$2K Buy
+1,200
New +$14.7K ﹤0.01% 2079

Other funds holding DXCM

M&T Bank's DXCM Position: Q2 2026 in Review

M&T Bank reduced its DexCom (DXCM) stake by 38% in Q2 2026, selling an estimated $685K and leaving 16,691 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #851.

M&T Bank first reported a position in DXCM in Q3 2014 and has held it in 46 quarters since. The position peaked at $6.05M in Q1 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • M&T Bank held 16,691 shares of DexCom worth $1.12M as of Q2 2026.
  • M&T Bank sold 10,287 DexCom shares in Q2 2026, an estimated $685K.
  • DexCom made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #851 holding.
  • M&T Bank first reported a position in DexCom in Q3 2014 and has held it in 46 quarters since.
  • M&T Bank's DexCom position peaked at $6.05M in Q1 2024.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.